Additional Covenants Clause Example with 5 Variations from Business Contracts

This page contains Additional Covenants clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Additional Covenants. 7.1 Board Composition and Board Designations. The Company shall ensure that: (i) the qualifications of the persons serving as members of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act, with the Exchange Act and with the listing rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system, and... (ii) if applicable, at least one member of the Audit Committee of the Board of Directors qualifies as an "audit committee financial expert," as such term is defined under Regulation S-K and the listing rules of the Exchange. 7.2 Prohibition on Press Releases and Public Announcements. The Company shall not issue press releases or engage in any other publicity, without the Representative's prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1st) Business Day following the forty-fifth (45th) day after the Closing Date, other than normal and customary releases issued in the ordinary course of the Company's business. View More
Found in DarioHealth Corp. contract

Variations of a "Additional Covenants" Clause from Business Contracts

Additional Covenants. 7.1 Board Composition and Board Designations. The Company shall ensure that: (i) that the qualifications of the persons serving as members of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act, with the Exchange Act and with the listing rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system..., and (ii) if applicable, at least one member of the Audit Committee of the Board of Directors qualifies as an "audit committee financial expert," as such term is defined under Regulation S-K and the listing rules of the Exchange. NASDAQ Capital Market. 7.2 Prohibition on Press Releases and Public Announcements. The Company shall will not issue press releases or engage in any other publicity, without the Representative's Underwriter's prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1st) Business Day following the forty-fifth (45th) day after the Closing Date, other than normal and customary releases issued in the ordinary course of the Company's business. business or in the reasonable judgment of the Company and its counsel, after notification to the Underwriter, such press release or communication is required by law. View More
Found in 2 Contracts from Xenetic Biosciences, Inc.
Additional Covenants. 7.1 6.1 Board Composition and Board Designations. The Company shall ensure that: (i) the qualifications of the persons serving as board members of the Board of Directors and the overall composition of the Board board comply with the Sarbanes-Oxley Act, with Act of 2002 and the Exchange Act rules promulgated thereunder and with the listing rules requirements of the Exchange NASDAQ or any other national securities exchange, exchange or national securities association, as the case may be, in the ev...ent the Company seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system, and (ii) if applicable, at least one member of the Audit Committee board of the Board of Directors directors qualifies as an "audit committee financial expert," a "financial expert" as such term is defined under Regulation S-K the Sarbanes-Oxley Act of 2002 and the listing rules of the Exchange. 7.2 promulgated thereunder. 22 6.2 Prohibition on Press Releases and Public Announcements. The Company shall will not issue press releases or engage in any other publicity, without the Representative's Underwriter's prior written consent, for a period ending at 5:00 p.m., p.m. Eastern time, time on the first (1st) Business Day business day following the forty-fifth (45th) 25th day after following the Closing Date, other than normal and customary releases issued in the ordinary course of the Company's business. View More
Found in SECOND SIGHT MEDICAL PRODUCTS INC contract
Additional Covenants. 7.1 8.1 Board Composition and Board Designations. The Company shall ensure that: (i) the qualifications of the persons serving as board members of the Board of Directors and the overall composition of the Board board comply with the Sarbanes-Oxley Act, with the Exchange Act and with the listing rules of the Exchange 2002 or any other national securities exchange, exchange or national securities association, as the case may be, in the event the Company seeks to have its Public Securities common s...tock listed on another exchange or quoted on an automated quotation system, exchange, and (ii) if applicable, at least one member of the Audit Committee board of the Board of Directors directors qualifies as an "audit committee financial expert," a "financial expert" as such term is defined under Regulation S-K the Sarbanes-Oxley Act of 2002 and the listing rules of the Exchange. 7.2 promulgated thereunder. 8.2 Prohibition on Press Releases and Public Announcements. The Company shall will not issue press releases or engage in any other publicity, without the Representative's Placement Agent's prior written consent, for a period ending at 5:00 p.m., P.M., Eastern time, Time, on the first (1st) Business Day business day following the forty-fifth (45th) fortieth (40th) day after following the Closing Date, Time, other than normal and customary releases issued in the ordinary course of the Company's business. View More
Found in Endurance Exploration Group, Inc. contract
Additional Covenants. 7.1 8.1 Board Composition and Board Designations. The Company shall ensure that: (i) the qualifications of the persons serving as board members of the Board of Directors and the overall composition of the Board board comply with the Sarbanes-Oxley Act, with Act of 2002 and the Exchange Act rules promulgated thereunder and with the listing rules requirements of the Exchange NASDAQ or any other national securities exchange, exchange or national securities association, as the case may be, in the ev...ent the Company seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system, and (ii) if applicable, at least one member of the Audit Committee board of the Board of Directors directors qualifies as an "audit committee financial expert," a "financial expert" as such term is defined under Regulation S-K the Sarbanes-Oxley Act of 2002 and the listing rules of the Exchange. 7.2 promulgated thereunder. 8.2 Prohibition on Press Releases and Public Announcements. The Company shall will not issue press releases or engage in any other publicity, without the Representative's prior written consent, for a period ending at 5:00 p.m., p.m. Eastern time, time on the first (1st) Business Day business day following the forty-fifth (45th) 25th day after following the Closing Date, other than normal and customary releases issued in the ordinary course of the Company's business. View More
Found in 2 Contracts from Pulse Biosciences, Inc.
Additional Covenants. 7.1 Board Composition and Board Designations. The Company shall ensure that: (i) the qualifications of the persons serving as members of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act, with the Exchange Act and with the listing rules of the Exchange NasdaqCM or any other national securities exchange, as the case may be, in the event the Company seeks to have any of its Public Securities securities listed on another exchange or quoted on an auto...mated quotation system, system , and (ii) if applicable, at least one member of the Audit Committee of the Board of Directors qualifies as an "audit committee financial expert," as such term is defined under Regulation S-K and the listing rules of the Exchange. NasdaqCM. 28 7.2 Prohibition on Press Releases and Public Announcements. The Company shall not issue press releases or engage in any other publicity, without the Representative's prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1st) Business Day following the forty-fifth (45th) fortieth (40th) day after the Closing Date, other than normal and customary releases issued in the ordinary course of the Company's business. View More
Found in Jaguar Health, Inc. contract